ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,116.17
0.32%
US Tech 100
17,312.80
0.42%
다우존스 지수
38,386.09
0.38%
Bitcoin
63,254.82
-0.91%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Deciphera Pharmaceuticals Inc (DCPH)

  7. Deciphera Pharmaceuticals Inc (DCPH) 뉴스

DCPH Deciphera Pharmaceuticals Inc

25.28
10.63 (72.56%)
30 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Deciphera Pharmaceuticals Inc DCPH 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
10.63 72.56% 25.28 08:57:40
개장가 저가 고가 종가 전일 종가
25.18 25.165 25.40 25.28 14.65
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/04/202420:00BWDeciphera Pharmaceuticals to be Acquired by ONO..
09/04/202420:00BWDeciphera Pharmaceuticals to Present at the Stifel 2024..
27/02/202421:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
21/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/02/202421:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/02/202421:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/02/202421:10EDGAR2Form 8-K - Current report
06/02/202421:00BWDeciphera Pharmaceuticals Announces Fourth Quarter and Full..
02/02/202406:50BWDeciphera Pharmaceuticals to Announce Fourth Quarter and..
01/02/202421:00BWDeciphera Pharmaceuticals to Present at the Guggenheim..
19/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202401:13BWDeciphera Pharmaceuticals Presents Long-Term Follow-Up..
08/01/202421:14EDGAR2Form 8-K - Current report
08/01/202421:00BWDeciphera Pharmaceuticals Announces Planned 2024 Corporate..
05/01/202421:00BWDeciphera Pharmaceuticals Announces Nature Medicine..
02/01/202421:00BWDeciphera Pharmaceuticals to Present at the 42nd Annual J.P...
15/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202308:05EDGAR2Form 144 - Report of proposed sale of securities
29/11/202321:00BWDeciphera Pharmaceuticals to Present at the JMP Securities..
07/11/202321:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
01/11/202305:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202305:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202320:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202320:06EDGAR2Form 8-K - Current report
30/10/202320:01BWDeciphera Pharmaceuticals Announces Third Quarter 2023..
30/10/202320:00BWDeciphera Pharmaceuticals Announces Positive Top-line..
29/09/202322:00PRNUSMedison Pharma Announces Public Formulary Listing of..
20/09/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/09/202306:00BWDeciphera Pharmaceuticals, Inc. Announces Inducement Grants..
06/09/202305:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/08/202305:05BWDeciphera Pharmaceuticals, Inc. Announces Inducement Grants..
09/08/202320:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202320:06EDGAR2Form 8-K - Current report
09/08/202320:00BWDeciphera Pharmaceuticals Announces Second Quarter 2023..
04/08/202305:20EDGAR2Form 8-K - Current report
04/08/202305:15BWDeciphera Pharmaceuticals Announces Retirement of Daniel L...
02/08/202320:00BWDeciphera Pharmaceuticals to Announce Second Quarter 2023..
26/05/202306:00BWDeciphera Pharmaceuticals to Present Data from INTRIGUE..
23/05/202320:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
08/05/202320:00BWDeciphera Pharmaceuticals to Present at the JMP Securities..

최근 히스토리

NASDAQ
DCPH
Deciphera Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유